Recall Enforment Report D-1438-2019
Recall Details
Multi event Drug Recall Enforcement Report Class III voluntary initiated by Amneal Pharmaceuticals, Inc., originally initiated on 09-25-2017 for the product Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-171-01 The product was recalled due to subpotent drug: out of specification assay result in esterified estrogen and methyltestosterone tablets.. The product was distributed nationwide and the recall is currently terminated.
Recall Enforcement Reports
Recall Number | Recall Initiation Date | Report Date | Recall Classification | Quantity | Product Description | Recall Reason | Status |
---|---|---|---|---|---|---|---|
D-1438-2019 | 09-25-2017 | 07-10-2019 | Class III | 19104 units | Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-171-01 | Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets. | Terminated |
D-1439-2019 | 09-25-2017 | 07-10-2019 | Class III | 19176 units | Esterified Estrogens & Methyltestosterone Tablets, USP 1.25 mg/2.5 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-172-01 | Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets. | Terminated |